Modulation of MAO activity by imidazoline and guanidine derivatives

Annals of the New York Academy of Sciences

Volumn 881, Issue , 1999, Pages 313-331

  Raasch, W ^a   Muhle, H ^a   Dominiak, P ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGMATINE; AMINE OXIDASE (FLAVIN CONTAINING); ANTAZOLINE; BDF 8082; BDF 8399; CATECHOLAMINE; CIRAZOLINE; CLONIDINE; EFAROXAN; GUANIDINE DERIVATIVE; IDAZOXAN; IMIDAZOLINE DERIVATIVE; MOXONIDINE; PARGYLINE; RILMENIDINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; BINDING AFFINITY; BINDING SITE; CONFERENCE PAPER; ENZYME ACTIVITY; ENZYME INHIBITION; MALE; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; NONHUMAN; RAT;

ANIMALIA; GYMNOMYZA SAMOENSIS;

EID: 0032787461     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb09376.x     Document Type: Conference Paper

References (45)

1. Bousquet, P., J. Feldman & D. Atlas. 1986. An endogenous, non-catecholamine clonidine antagonist increases mean arterial blood pressure. Eur. J. Pharmacol. 124: 167-170.
2. Ernsberger, P., M. P. Meeley, J. Mann & D. J. Reis. 1987. Clonidine binds to imidazole binding sites as well as alpha 2-adrenoceptors in the ventrolateral medulla. Eur. J. Pharmacol. 134: 1-13.
3. Bousquet, P., J. Feldman, E. Tibirica, G. Bricca, H. Greney, M. Dontenwill, J. Stutzmann & A. Belcourt. 1992. Imidazoline receptors. A new concept in central regulation of the arterial blood pressure. Am. J. Hypertens. 5: 45S-50S.
4. Haxhiu, M. A., A. Dreshaj, S. Schäfer & P. Ernsberger. 1994. Selective antihypertensive action of moxonidine is mediated mainly by I1-imidazoline receptors in the rostral ventrolateral medulla. J. Cardiovasc. Pharmacol. 24: 1-8.
5. Szabo, B. 1996. Mechanism of the sympathoinhibition by clonidine-like drugs. Naunyn-Schmiedeberg's Arch. Pharmacol. 353; S15.
6. Mac Kinnon, A. C., M. Stewart, H. J. Olverman, M. Spedding & C. M. Brown. 1993. [3H]p-aminoclonidine and [3H]idazoxan label different populations of imidazoline sites on rat kidney. Eur. J. Pharmacol. 232: 79-87.
7. Piletz, J. E. & K. Sletten. 1993. Nonadrenergic imidazoline binding sites on human platelets. J. Pharmacol. Exp. Ther. 267: 1493-1502.
8. Berdeu, D., R. Gross, R. Puech, M. M. Loubatieres-Mariani & G. Berrand. 1995. Evidence for two different imidazoline sites on pancreatic B cells and vascular bed in rat. Eur. J. Pharmacol. 275: 91-98.
9. Tesson, F., C. Prip-Buus, A. Lemoine, A. Pegorier & A. Parini. 1991. Subcellular distribution of imidazoline-guanidinium-receptive sites in human and rabbit liver. Major localization to the mitochondrial outer membrane. J. Biol. Chem. 266: 155-160.
10. Tesson, F. & A. Parini. 1991. Identification of an imidazoine-guanidinium receptive site in mitochondria from rabbit cerebral cortex. Eur. J. Pharmacol. 208: 81-83.
11. Carpéné, C., P. Collan, A. Remaury, A. Cordi, A. Hudson, D. Nutt & M. Lafontan. 1995. Inhibition of amine oxidase activity by derivatives that recognize imidazoline 12 sites. J. Pharmacol. Exp. Ther. 272: 681-688.
12. Lowry, O. H., N. J. Rosebrough, A. L. Farr & R. J. Randall. 1951. Protein measurement with the folin reagent. J. Biol. Chem. 193: 265-275.
13. Raasch, W., F. Kees & H. Grobecker. 1992. Influence of ciprofloxacin on brain metabolism of biogenic amines in the rat. Pharm. Pharmacol. Lett. 2: 153-156.
14. 2 specific ligands in vitro. Pharm. Pharmacol. Lett. 1:42-45.
15. Erikson, B. M. & B. A. Persson. 1982. Determination of catecholamines in rat heart tissue and plasma samples by liquid chromatography with electrochemical detection. J. Chromatogr. 228: 143-154.
16. Estabrook, R. 1967. Mitochondrial respiration control and the polarographic measurement of ADP:O ratio. Methods Enzymol. 10: 41-47.
17. Michel, M. C. & P. A. Insel. 1989. Are there multiple imidazoline binding sites? Trends Pharmacol. Sci. 10: 342-344.
18. Tesson, F., J. Limon-Boulez, P. Urban, M. Puype, J. Vandekerchkove, J. Coupry, D. Pompon & A. Parini. 1995. Localization of I2-imidazoline binding sites on monoamine oxidases. J. Biol. Chem. 270: 9856-9861.
19. Ernsberger, P. R., K. L. Westbrooks, M. O. Christen & S. G. Schäfer. 1992. A second generation of centrally acting antihypertensive agents act on putative I1-imidazoline receptors. J. Cardiovasc. Pharmacol. 20: S1-S10.
20. Miralles, A., G. Olmos, M. Sastre, F. Barturen, I. Martin & J. A. Garcia-Sevilla. 1993. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha2 adrenoceptors with [3H]RX821002 (2-methoxy-idazoxan) in the human and rat brains. J. Pharmacol. Exp. Ther. 264: 1187-1197.
21. Lione, L. A., D. J. Nutt & A. L. Hudson. 1996. [3H]2-(2Benzofuranyl)-2-imidazoline: A new selective high affinity radioligand for the study of rabbit brain imidazoline I2 receptors. Eur J. Pharmacol. 304: 221-229.
22. Wiest, S. A. & M. I. Steinberg. 1997. Binding of [3H]2-(2Benzofuranyl)-2-imidazoline (BFI) to human brain: Potentiation by tranylcypromine. Life Sci. 60: 605-615.
23. Raddatz, R., A. Parini & S. M. Lanier. 1995. Imidazoline/guanidinium binding domains on monoamine oxidase: Relationship to subtypes of imidazoline-binding proteins and tissue-specific interaction of imidazoline ligands with monoamine oxidase B. J. Biol. Chem. 270: 27961-27968.
24. +1. J. Pharmacol. Exp. Ther. 276: 359-364.
25. Maycock, A. L., R. H. Abeles, J. I. Salach & T. P. Singer. 1976. The action of acetylenic inhibitors on mitochondrial monoamine oxidase: Structure of the flavin site in the inhibited enzyme. Ciba Foundation Symposium (New Ser) Elsevier Amsterdam 39: 37-47.
26. 14C]-deprenyl. Mol. Pharmacol. 16: 234-241.
27. Raddatz, R. & S. M. Lanier. 1997. Relationship between imidazoline/guanidinium receptive sites and monoamineoxidase A and B. Neurochem. Int. 30: 109-117.
28. Bach, A. W., N. C. Lan, P. L. Johnson, C. B. Abell, M. E. Bembenek, S. W. Kwan, P. H. Seeburg & J. C. Smith. 1988. cDNA cloning of human liver monoamine oxidase A and B. Molecular basis of differences in enzymatic properties. Proc. Natl. Acad. Sci. USA 85: 4934-4938.
29. Escribá, P. V., R. Alemany, M. Sastre, G. Olmos, A. Ozaita & J. A. Garcia-Sevilla. 1996. Pharmacological modulation of immunoreactive imidazoline receptor proteins in rat brain: Relationship with non-adrenoceptor [3H]-idazoxan binding sites. Br. J. Pharmacol. 118: 2029-2036.
30. Leclerc, G., B. Rouot, J. Schwartz, J. Velly & C. G. Wermuth. 1980. Studies on some para-substituted clonidine derivatives that exhibit an alpha-adrenoceptor stimulant activity. Br. J. Pharamacol. 71: 5-9.
31. Li, G., S. Regunathan, C. W. Barrow, J. Esphraghi, R. Cooper & D. J. Reis. 1994. Agmatine: An endogenous clonidine-displacing substance in the brain. Science 263: 966-969.
32. Raasch, W., S. Regunathan, G. Li & D. J. Reis. 1995. Agmatine, the bacterial amine, is widely distributed in mammalian tissues. Life Sci. 56: 2319-2330.
33. Raasch, W., S. Regunathan, G. Li & D. J. Reis. 1995. Agmatine is widely and unequally distributed in rat organs. Ann. N.Y. Acad. Sci. 763: 330-334.
34. Gilad, G. M., Y. Wollam, A. Iaina, J. M. Rabey, T. Chernihovsy & V. H. Gilad. 1996. Metabolism of agmatine into urea but not into nitric oxide in rat brain. Neuroreport 7: 1730-1732.
35. Sastre, M., S. Regunathan, E. Galea & D. J. Reis. 1996. Agmatinase activity in rat brain: A metabolic pathway for the degradation of agmatine. J. Neurochem. 67: 1761-1765.
36. Smith, G. S. & R. A. Reis. 1978. The influence of respiratory state on monoamine oxidase activity in rat liver mitochondria. Biochem. J. 176: 1011-1014.
37. Wojtczak, A. B., D. Brdiczka & L. Woijtczak. 1995. Is monoamine oxidase activity in the outer mitochondrial membrane influenced by the mitochondrial respiratory state. Biochim. Biophys. Acta 1229: 249-255.
38. Harris, E. J. & M. B. Cooper. 1982. Monoamine oxidase activity of mitochondria prepared from rat liver and heart rate. J. Neurochem. 38: 1068-1071.
39. Atkinson, J., N. Boillat, T. Dennis, S. Z. Langer & B. Scatton. 1987. Effect of prolonged clonidine treatment and its withdrawal on noradrenaline turnover in the cerebral cortex and medulla oblongata of the spontaneously hypertensive rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 336: 77-80.
40. Braden, G., R. Alvis, B. R. Walker & M. Cox. 1987. Effects of guanabenz on sodium and water homeostatis. J. Clin. Hypertens. 3: 397-404.
41. Feldman, J. M. 1988. Effect of monoamine oxidase inhibitors clorgyline and pargyline on the hyperphagia of obese mice. Behav. Brain. Res. 29: 147-158.
42. Kuenzel, W. J., N. Snapir & C. E. Rexroad, Jr. 1987. Food intake and biogenic amine concentrations in brain regions of chicks following intracerebroventricular injection of 6-hydroxydopamine. Pharmacol. Biochem. Behav. 27: 257-263.
43. Olmos, G., A. Miralles, F. Barturen & J. A. Garcia-Sevilla. 1991. Characterization of brain imidazoline receptors in normotensive and hypertensive rats: Differential regulation by chronic imidazoline drug treatment. J. Pharmacol. Exp. Ther. 260: 1000-1007.
44. Gargalides-moundanos, C., N. Pizzinat, F. Javoy-Agid, A. Remaury & A. Parini. 1997. I2-imidazoline binding sites and monoamine oxidase activity in human postmortem brain from patients with Parkinson's disease. Neurochem. Int. 30: 31-36.
45. Fowler, C. J. & L. Oreland. 1980. The nature of the substrate-selective interaction between rat liver mitochondrial monoamine oxydase and oxygen. Biochem. Pharmacol. 29: 2225-2233.